Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Sernova Corp
Bullboard Posts
User Avatar Image
(168)
•••
Post by jwalliscaon Nov 18, 2019 5:45pm
102 Views
Post# 30367053

Redbaron2211 Thanks: some new stuff :)

Redbaron2211 Thanks: some new stuff :)Rb2211:

The link you gave from Sernova's website is reproduced below (two methods) hopefully as live links.
https://www.sernova.com/pdf/updates/Sernova%20Diabetes%20Canada%20T1D%20Toronto.pdf

16 - 11 - 2019 Toronto Talk by Dr. Toleikis

There is some new information tucked away on slides 19 (C-Peptide to 180 days) and slide 23 hints at avoiding immunosuppression. This doesn't appear in the earlier November presentation; see link below. This presentation has disappeared from Sernova's website!
n.b. The 180 day data suggest all is well with The Pouch and matters continue to improve!

https://www.sernova.com/pdf/updates/Sernova%20Corp%20Presentation%20November%202019.pdf

My take is Sernova is keeping things as quiet as it can for a business  reason of which I have no clue.

jwall
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities